Bankrupt cable television provider Adelphia Communications Corp. has turned up the heat on its former law firm after deciding Tuesday to launch an investigation into its attorneys' alleged conflict of interest.
Former Gemstar CEO Henry Yuen’s plea bargain, which raised cries of protest for its relative leniency, has been denied by a judge, sending the executive and federal prosecutors back to the bargaining table.
Ameriquest Mortgage Co., the largest privately held mortgage firm in the United States, has agreed to pay $325 million to settle one of the most widespread cases of predatory lending in the country’s history.
Shareholders of America Online’s bankrupt Latin American division have proposed a liquidation plan that will allow unsecured creditors to recover 100% of their claims, but only if they agree not to hold them liable for the Internet unit’s collapse.
Shareholders of grocery store chain Winn-Dixie will no longer have a say in the struggling company’s bankruptcy proceedings after a judge disbanded the equity committee in Winn-Dixie’s Chapter 11 case.
A now-defunct Kentucky college that owes over $3 million in loans taken out by its former chief executive should not be liquidated, according to a Kentucky bank, because the sale of all the school’s assets would still not be enough to pay back the borrowed money.
Continuing its probe of the lightly-regulated hedge fund industry, the Securities and Exchange Commission is eyeing investment manager Perry Capital LLC regarding questionable trading techniques that allowed the firm to influence a pharmaceutical company’s takeover plans.
The problems facing drug-testing firm SFBC International expanded this week when the Securities and Exchange Commission issued an informal request for documents related to two executives who recently left the company.
A tiny electric engine maker filed a complaint Wednesday with the U.S. International Trade Commission against auto giant Toyota for infringing on its patented hybrid car technology. The action comes just four months after another suit was filed against Toyota by Solomon in a Florida District Court, which has been stalled due to troubles financing the litigation.
In the epilogue to an acrimonious battle over a drug that could be worth billions of dollars, a federal jury has ordered a California biotechnology company to pay an additional $30 million in punitive damages to a small family-owned pharmaceutical company whose patents it illegally licensed.
The European Union has caved in under pressure from the U.S. and Australia to simplify its registration procedure for foreign agricultural products after a protracted food fight over geographic indications.
The U.S. Securities and Exchange Commission has openly criticized the Justice Department’s plea agreement with former Gemstar CEO Henry Yuen, telling a judge that prosecutors may have been too lenient in settling with the embattled executive.
After a six-year feud over a potential blockbuster drug, a small family-owned pharmaceutical company has been awarded $48 million from a biotechnology firm accused of illegally licensing its patents.
A judge has delayed the sentencing of former Gemstar CEO Henry Yuen, saying that the penalty agreed to in the plea bargain is too lenient for the former executive, accused of aiding in a $248 million fraud.
Extending the drawn-out legal row over generic Wellbutrin, a subsidiary of Andrx Pharmaceuticals LLC has sued British rival GlaxoSmithKline PLC, alleging the company’s current formula for the antidepressant infringes Andrx’s patent.
Johnson & Johnson subsidiary Ethicon Endo-Surgery has accused a rival of reprocessing its single-use surgical scalpels and reselling them to hospitals without removing the Ethicon service mark, thereby infringing the company’s trademark.
Morrison & Foerster LLP, a powerhouse in securities litigation in the United States, traces much of its success to the firm's extensive presence in Asia.
Morgan Stanley has appealed the $1.45 billion award won by financier Ronald Perelman earlier this year in a dispute over Perelman’s sale of camping-gear company to Sunbeam Corp. in 1998.
A Johnson & Johnson medical device prevailed in the U.S. Court of Appeals for the Sixth Circuit when the doctor that sued the company for trade secret violations failed to show proper similarity between his heart surgery device and J&J’s alleged copy.
The Securities and Exchange Commission has reached a $25 million settlement with a company it probed for allegedly defrauding thousands of terminally ill patients by manipulating their life insurance policies.